The health ministry said Monday it has found documents with the names or initials of 118 out of 418 people who developed hepatitis C from a tainted blood product, reversing its earlier claim that it had no data to confirm any of their identities.</PARAGRAPH>
<PHOTO>
<TABLE WIDTH='250' ALIGN='RIGHT' BORDER='0'>
<TR>
<TD><IMG ALT='News photo' BORDER='0' SRC='../images/photos2007/nn20071023a3a.jpg' WIDTH='250' HEIGHT='163'/></TD>
</TR>
<TR>
<TD><FONT SIZE='1'><B>Mitsubishi Tanabe Pharma Corp. President Natsuki Hayama –
and Vice President Takeshi
Komine (right) face reporters at the health ministry Monday.
KYODO PHOTO
The 118 are among 418 hepatitis C patients infected by tainted fibrinogen made by the now-defunct blood product maker Green Cross Corp.
In a time of both misinformation and too much information, quality journalism is more crucial than ever. By subscribing, you can help us get the story right.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name
in the Profile section of your subscriber account page.
Your subscription plan doesn't allow commenting. To learn more see our FAQ
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.